Overview of Dr. Schmitt
Dr. Adam Schmitt is a radiation oncologist in New York, NY and is affiliated with multiple hospitals in the area, including Memorial Sloan Kettering Cancer Center and Memorial Hospital for Cancer and allied Diseases. He received his medical degree from University of Chicago Division of the Biological Sciences The Pritzker School of Medicine and has been in practice 8 years. He is one of 106 doctors at Memorial Sloan Kettering Cancer Center and one of 26 doctors at Memorial Hospital for Cancer and allied Diseases who specialize in Radiation Oncology. He has more than 30 publications and over 500 citings.
Office
1275 York Ave
New York, NY 10065
Education & Training
- Stanford Health Care-Sponsored Stanford UniversityResidency, Radiation Oncology, 2010 - 2014
- University of ChicagoResidency, Internal Medicine, 2009 - 2010
- University of Chicago Division of the Biological Sciences The Pritzker School of MedicineClass of 2009
Certifications & Licensure
- CA State Medical License 2010 - Present
- FL State Medical License 2023 - Present
- NY State Medical License 2014 - 2026
- NJ State Medical License 2021 - 2025
- IL State Medical License 2009 - 2010
- American Board of Radiology Radiation Oncology
Publications & Presentations
PubMed
- 40 Gray in 5 Fractions for Salvage Reirradiation of Spine Lesions Previously Treated With Stereotactic Body Radiotherapy.Assaf Moore, Zhigang Zhang, Teng Fei, Lei Zhang, Laura Accomando
Neurosurgery. 2024-08-01 - Chordoma arising from the coccygeal disc and mimicking a pilonidal cyst.Michael Mazzucco, Sinchun Hwang, Konstantinos Linos, Meera Hameed, Farooq Shahzad
Skeletal Radiology. 2024-07-01 - Biomarkers associated with pulmonary exacerbations in a randomized trial of nintedanib for radiation pneumonitis.Zachary R Moore, Xiaojing Huang, Stephanie Lobaugh, Zhigang Zhang, Phillip Wong
Radiotherapy and Oncology. 2024-07-01
Press Mentions
- Reducing Cardiovascular Disease in Cancer SurvivorsDecember 24th, 2022
- Mouse Study Suggests New Therapeutic Strategy to Reduce Cardiovascular Disease in Cancer SurvivorsDecember 19th, 2022
- New Discovery Could Reduce the Risk of Heart Damage Among Cancer PatientsDecember 19th, 2022
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: